Investment firm Silversmith Capital Partners successfully closes their fifth fund, worth a significant $1.7 billion.
Silversmith Capital Partners Announces Successful Close of Fifth Fund with $1.7 Billion
Silversmith Capital Partners, a renowned growth equity firm, has announced the final close of their fifth fund, Fund V, with a total commitment of $1.7 billion. This latest fund marks a significant milestone in the firm's 10-year journey, during which it has raised over $5 billion in capital.
Fund V's strategy and focus remain consistent with Silversmith's prior funds. The firm will continue to make minority and majority investments in growth-stage technology and healthcare companies, embodying their commitment to backing exceptional founders who are solving real problems.
Sri Rao, who has been integral to Silversmith's growth since 2015, has been named the managing partner of the firm. Todd MacLean, Managing Partner of Silversmith Capital Partners, praises Rao for embodying the firm's approach, leading with humility, putting founders first, and bringing deep domain expertise. Jim Quagliaroli, another Managing Partner, affirms that any founder worked with by Rao would say he builds trust, meets founders where they are, and is a steady partner.
The quick oversubscription and hard cap close of Fund V reflect strong conviction from Silversmith's existing investor base. Over 70% of the capital for Fund V comes from the first institutional investor, while the remaining comes from many long-time limited partners and more than 50 senior executives.
Kirkland & Ellis provided fund formation counsel for Silversmith Capital Partners' Fund V. The firm's approach is characterized by disciplined execution and a founder-first approach, aimed at partnering with entrepreneurs building enduring businesses in the technology and healthcare sectors. They bring strategic perspective and a long-term partnership focus to accelerate growth for management teams.
The commitment to backing exceptional founders solving real problems has guided every fund raised by Silversmith Capital Partners. With Fund V, the firm looks forward to continuing this mission, helping to drive growth and innovation in the technology and healthcare industries.
- With the successful close of Fund V, Silversmith Capital Partners, a growth equity firm, has secured $1.7 billion for investing in growth-stage technology and healthcare companies, furthering their mission of collaborating with exceptional founders to deliver solutions for real problems.
- In the finance industry, strategic partnerships are essential, and with Fund V, Silversmith Capital Partners continues their focus on growth equity, aiming to develop business relationships that foster innovation and growth, particularly within the technology and healthcare sectors.
